|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar
|
|
2
|
Brandao GD, Brega EF and Spatz A: The role
of molecular pathology in non-small-cell lung carcinoma-now and in
the future. Curr Oncol. 19(Suppl 1): S24–S32. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wegner M: From head to toes: the multiple
facets of Sox proteins. Nucleic Acids Res. 27:1409–1420. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Harley VR, Lovell-Badge R and Goodfellow
PN: Definition of a consensus DNA binding site for SRY. Nucleic
Acids Res. 22:1500–1501. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wegner M: All-purpose Sox: the many roles
of Sox proteins in gene expression. Int J Biochem Cell Biol.
42:381–390. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Francois M, Koopman P and Beltrame M: SoxF
genes: key players in the development of the cardio-vascular
system. Int J Biochem Cell Biol. 42:445–448. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cermenati S, Moleri S, Cimbro S, et al:
Sox18 and Sox7 play redundant roles in vascular development. Blood.
111:2657–2666. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hosking B, Francois M, Wilhelm D, et al:
Sox7 and Sox17 are strain-specific modifiers of the lymphangiogenic
defects caused by Sox18 dysfunction in mice. Development.
136:2385–2391. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Matsui T, Kanai-Azuma M, Hara K, et al:
Redundant roles of Sox17 and Sox18 in postnatal angiogenesis in
mice. J Cell Sci. 119:3513–3526. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sakamoto Y, Hara K, Kanai-Azuma M, et al:
Redundant roles of Sox17 and Sox18 in early cardiovascular
development of mouse embryos. Biochem Biophys Res Commun.
360:539–544. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Herpers R, van de Kamp E, Duckers HJ and
Schulte-Merker S: Redundant roles for sox7 and sox18 in
arteriovenous specification in zebrafish. Circ Res. 102:12–15.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Downes M, Francois M, Ferguson C, et al:
Vascular defects in a mouse model of
hypotrichosis-lymphedema-telangiectasia syndrome indicate a role
for SOX18 in blood vessel maturation. Hum Mol Genet. 18:2839–2850.
2009. View Article : Google Scholar
|
|
13
|
Francois M, Caprini A, Hosking B, et al:
Sox18 induces development of the lymphatic vasculature in mice.
Nature. 456:643–647. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Irrthum A, Devriendt K, Chitayat D, et al:
Mutations in the transcription factor gene SOX18 underlie recessive
and dominant forms of hypotrichosis-lymphedema-telangiectasia. Am J
Hum Genet. 72:1470–1478. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Darby IA, Bisucci T, Raghoenath S, et al:
Sox18 is transiently expressed during angiogenesis in granulation
tissue of skin wounds with an identical expression pattern to Flk-1
mRNA. Lab Invest. 81:937–943. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Young N, Hahn CN, Poh A, et al: Effect of
disrupted SOX18 transcription factor function on tumor growth,
vascularization, and endothelial development. J Natl Cancer Inst.
98:1060–1067. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Duong T, Proulx ST, Luciani P, et al:
Genetic ablation of SOX18 function suppresses tumor
lymphangiogenesis and metastasis of melanoma in mice. Cancer Res.
72:3105–3114. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Saitoh T and Katoh M: Expression of human
SOX18 in normal tissues and tumors. Int J Mol Med. 10:339–344.
2002.PubMed/NCBI
|
|
19
|
Pula B, Olbromski M, Wojnar A, et al:
Impact of SOX18 expression in cancer cells and vessels on the
outcome of invasive ductal breast carcinoma. Cell Oncol (Dordr).
36:469–483. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Eom BW, Jo MJ, Kook MC, et al: The
lymphangiogenic factor SOX 18: a key indicator to stage gastric
tumor progression. Int J Cancer. 131:41–48. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Garcia-Ramirez M, Martinez-Gonzalez J,
Juan-Babot JO, et al: Transcription factor SOX18 is expressed in
human coronary atherosclerotic lesions and regulates DNA synthesis
and vascular cell growth. Arterioscler Thromb Vasc Biol.
25:2398–2403. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dammann R, Strunnikova M, Schagdarsurengin
U, et al: CpG island methylation and expression of
tumour-associated genes in lung carcinoma. Eur J Cancer.
41:1223–1236. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Azhikina T, Kozlova A, Skvortsov T and
Sverdlov E: Heterogeneity and degree of TIMP4, GATA4, SOX18, and
EGFL7 gene promoter methylation in non-small cell lung cancer and
surrounding tissues. Cancer Genet. 204:492–500. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Detterbeck FC, Boffa DJ and Tanoue LT: The
new lung cancer staging system. Chest. 136:260–271. 2009.
View Article : Google Scholar
|
|
25
|
Remmele W and Stegner HE: Recommendation
for uniform definition of an immunoreactive score (IRS) for
immunohisto-chemical estrogen receptor detection (ER-ICA) in breast
cancer tissue. Pathologe. 8:138–140. 1987.(In German).
|
|
26
|
Werynska B, Pula B, Muszczynska-Bernhard
B, et al: Metallothionein 1F and 2A overexpression predicts poor
outcome of non-small cell lung cancer patients. Exp Mol Pathol.
94:301–308. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Doroudi R, Andersson M, Svensson PA, et
al: Methodological studies of multiple reference genes as
endogenous controls in vascular gene expression studies.
Endothelium. 12:215–223. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lefebvre V, Dumitriu B, Penzo-Mendez A, et
al: Control of cell fate and differentiation by Sry-related
high-mobility-group box (Sox) transcription factors. Int J Biochem
Cell Biol. 39:2195–2214. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wilson M and Koopman P: Matching SOX:
partner proteins and co-factors of the SOX family of
transcriptional regulators. Curr Opin Genet Dev. 12:441–446. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhu Y, Li Y, Jun Wei JW and Liu X: The
role of sox genes in lung morphogenesis and cancer. Int J Mol Sci.
13:15767–15783. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yin D, Jia Y, Yu Y, et al: SOX17
methylation inhibits its antagonism of Wnt signaling pathway in
lung cancer. Discov Med. 14:33–40. 2012.PubMed/NCBI
|
|
32
|
Tessema M, Willink R, Do K, et al:
Promoter methylation of genes in and around the candidate lung
cancer susceptibility locus 6q23-25. Cancer Res. 68:1707–1714.
2008. View Article : Google Scholar
|
|
33
|
Hayano T, Garg M, Yin D, et al: SOX7 is
down-regulated in lung cancer. J Exp Clin Cancer Res. 32:172013.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li B, Ge Z, Song S, et al: Decreased
expression of SOX7 is correlated with poor prognosis in lung
adenocarcinoma patients. Pathol Oncol Res. 18:1039–1045. 2012.
View Article : Google Scholar : PubMed/NCBI
|
